Kuwait · Delayed Price · Currency is KWD · Price in KWF KWSE:NIH Statistics
Total Valuation
KWSE:NIH has a market cap or net worth of KWD 34.64 million. The enterprise value is 34.91 million.
| Market Cap | 34.64M |
| Enterprise Value | 34.91M |
Important Dates
The next estimated earnings date is Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KWSE:NIH has 245.64 million shares outstanding. The number of shares has increased by 1.26% in one year.
| Current Share Class | 245.64M |
| Shares Outstanding | 245.64M |
| Shares Change (YoY) | +1.26% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.55% |
| Owned by Institutions (%) | n/a |
| Float | 154.24M |
Valuation Ratios
The trailing PE ratio is 12.36.
| PE Ratio | 12.36 |
| Forward PE | n/a |
| PS Ratio | 3.72 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.78 |
| P/FCF Ratio | 35.61 |
| P/OCF Ratio | 33.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.29, with an EV/FCF ratio of 35.90.
| EV / Earnings | 12.47 |
| EV / Sales | 3.75 |
| EV / EBITDA | 7.29 |
| EV / EBIT | 7.48 |
| EV / FCF | 35.90 |
Financial Position
The company has a current ratio of 7.29, with a Debt / Equity ratio of 0.04.
| Current Ratio | 7.29 |
| Quick Ratio | 6.47 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.48 |
| Debt / FCF | 2.37 |
| Interest Coverage | 20.53 |
Financial Efficiency
Return on equity (ROE) is 5.81% and return on invested capital (ROIC) is 5.58%.
| Return on Equity (ROE) | 5.81% |
| Return on Assets (ROA) | 5.16% |
| Return on Invested Capital (ROIC) | 5.58% |
| Return on Capital Employed (ROCE) | 8.33% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.16 |
| Inventory Turnover | 3.64 |
Taxes
In the past 12 months, KWSE:NIH has paid 14,804 in taxes.
| Income Tax | 14,804 |
| Effective Tax Rate | 0.51% |
Stock Price Statistics
The stock price has decreased by -61.78% in the last 52 weeks. The beta is 0.20, so KWSE:NIH's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -61.78% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.15 |
| Relative Strength Index (RSI) | 45.07 |
| Average Volume (20 Days) | 1,379,795 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KWSE:NIH had revenue of KWD 9.31 million and earned 2.80 million in profits. Earnings per share was 0.01.
| Revenue | 9.31M |
| Gross Profit | 6.43M |
| Operating Income | 4.67M |
| Pretax Income | 2.91M |
| Net Income | 2.80M |
| EBITDA | 4.79M |
| EBIT | 4.67M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 8.83 million in cash and 2.31 million in debt, giving a net cash position of 6.53 million or 0.03 per share.
| Cash & Cash Equivalents | 8.83M |
| Total Debt | 2.31M |
| Net Cash | 6.53M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 51.36M |
| Book Value Per Share | 0.18 |
| Working Capital | 10.32M |
Cash Flow
In the last 12 months, operating cash flow was 1.04 million and capital expenditures -66,374, giving a free cash flow of 972,513.
| Operating Cash Flow | 1.04M |
| Capital Expenditures | -66,374 |
| Free Cash Flow | 972,513 |
| FCF Per Share | 0.00 |
Margins
Gross margin is 69.06%, with operating and profit margins of 50.15% and 30.09%.
| Gross Margin | 69.06% |
| Operating Margin | 50.15% |
| Pretax Margin | 31.23% |
| Profit Margin | 30.09% |
| EBITDA Margin | 51.48% |
| EBIT Margin | 50.15% |
| FCF Margin | 10.45% |
Dividends & Yields
KWSE:NIH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 0.83% |
| Buyback Yield | -1.26% |
| Shareholder Yield | -1.26% |
| Earnings Yield | 8.09% |
| FCF Yield | 2.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 5, 2025. It was a forward split with a ratio of 1.06.
| Last Split Date | Aug 5, 2025 |
| Split Type | Forward |
| Split Ratio | 1.06 |
Scores
KWSE:NIH has an Altman Z-Score of 5.35 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.35 |
| Piotroski F-Score | 7 |